XML 54 R44.htm IDEA: XBRL DOCUMENT v3.8.0.1
Common Stock (Details) - USD ($)
 1 Months Ended 6 Months Ended
Aug. 11, 2017
Nov. 30, 2017
Oct. 31, 2017
Sep. 30, 2017
Aug. 31, 2017
Dec. 31, 2017
Jun. 30, 2017
Common Stock (Textual)              
Common stock, par value           $ 0.0001 $ 0.0001
Common stock, shares authorized           100,000,000 100,000,000
Common stock, shares outstanding           4,894,638 824,831
Preferred stock, par value           $ 0.0001 $ 0.0001
Preferred stock, shares authorized           50,000,000 50,000,000
Preferred stock, shares issued           1,900 0
Preferred stock, shares outstanding           1,900 0
Gross proceeds $ 11,800,000            
Increase common shares outstanding 750,000            
Stock issued in offering   495,000          
Warrants to purchase of common stock         6,314,671    
Unrecognized expense           $ 1,372,000  
Fair value of restricted stock       $ 1,400,000      
Restricted vest       Sep. 30, 2027      
Revenue earn out payment     $ 238,000        
Description of unrecognized expense       The expense associated with the restricted shares granted will be recognized using the straight-line method over the 10-year vesting period.      
2015 Stock Option and Inventive Plan [Member]              
Common Stock (Textual)              
Aggregate stock compensation expenses           $ 36,000  
Issuance of restricted stock, shares   3,000       8,250  
Fair value of restricted stock   $ 695,000       $ 26,000  
Restricted vest   Nov. 30, 2027          
Description of unrecognized expense           Aytu previously issued 43,000 shares of restricted stock outside the Aytu BioScience 2015 Stock Option and Inventive Plan, which vest in July 2026. The unrecognized expense related to these shares was $1,912,000 as of December 31, 2017 and will be recognized over the 10-year vesting period. During the six months ended December 31, 2017, the expense related to these awards was $78,000.  
Preferred Stock [Member]              
Common Stock (Textual)              
Preferred stocks converted in common stock     350     (350)  
Issuance of restricted stock, shares            
Issued of common stock payment to Nuelle Shareholders for fiscal 2018            
Common Stock [Member]              
Common Stock (Textual)              
Preferred stocks converted in common stock     116,666     116,666  
Stock issued in offering 3,196,665     200,000      
Issuance of restricted stock, shares           692,000  
Issued of common stock payment to Nuelle Shareholders for fiscal 2018       3,018   64,150  
Series A Preferred Stock [Member]              
Common Stock (Textual)              
Common stock, shares outstanding           735,000  
Preferred stock, shares issued           10,000  
Price per share $ 3.00            
Stock issued in offering 2,250            
Cash fee, percentage 9.00%            
Warrants purchase, percentage 10.00%            
Warrants to purchase of common stock 6,314,671            
Warrants issued to underwriters as compensation for transaction 394,669            
Class A Units [Member]              
Common Stock (Textual)              
Sale of stock, description Class A units consist of one (1) share of common stock and a warrant to purchase one and one-half (1.5) shares of common stock and were sold at a negotiated price of $3.00 per unit.            
Class B Units [Member]              
Common Stock (Textual)              
Sale of stock, description Class B units consist of one (1) share of our newly created Series A Convertible Preferred Stock (the "Series A Preferred Stock") and warrants to purchase one and one-half (1.5) shares of common stock for each share of common stock into which the Series A Preferred Stock is convertible and were sold at a negotiated price of $1,000.00 per unit to those purchasers who, together with their affiliates and certain related parties, would beneficially own more than 9.99% of our outstanding common stock following the offering.